AGAP2 and metastatic malignant neoplasm in the lymph nodes: The statistical analysis showed that a higher AGAP2-AS1 level was associated with larger tumors (P = 0.010), advanced pathological stage (P = 0.001), and lymph node metastasis (P = 0.022).